Paclitaxel poliglumex clinical trials
Also written Xyotax, CT-2103 and PG-TXL.
How each study uses paclitaxel poliglumex is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
19 studies that test it; most in 2005 (4)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 15
CTI BioPharma (4) · Gynecologic Oncology Group (2) · University of Southern California (2) · State University of New York - Upstate Medical University (1) · Brown University (1) · Alliance for Clinical Trials in Oncology (1) · The Methodist Hospital Research Institute (1) · Dartmouth-Hitchcock Medical Center (1)
Often tested with
Tested in the same studies.
Carboplatin (4) · Capecitabine (2) · Cetuximab (1) · Pemetrexed (1) · Paclitaxel (1) · Estradiol (1) · Doxorubicin (1) · Cyclophosphamide (1)
Studies
Open first, then newest update. How each study uses paclitaxel poliglumex is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 19
- A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck CancerCompletedPhase 1/2State University of New York - Upstate Medical UniversityNCT00660218Written as paclitaxel poliglumexHow we know
- Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube CancerStatus unknownPhase 3GOG FoundationNCT00108745Written as Paclitaxel PoliglumexHow we know
- A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.TerminatedPhase 3CTI BioPharmaNCT00269828Written as paclitaxel poliglumexHow we know
- CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mLWithdrawnPhase 3CTI BioPharmaNCT00576225Written as CT-2103/carboplatinHow we know
- Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerTerminatedPhase 3CTI BioPharmaNCT00551733Written as paclitaxel poliglumexHow we know
- PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT MethylationCompletedPhase 2Brown UniversityNCT01402063Written as PPX (CT2103)How we know
- CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedPhase 2Gynecologic Oncology GroupNCT00045682Written as Paclitaxel PoliglumexHow we know
- Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast CancerWithdrawnPhase 2University of Southern CaliforniaNCT01227408Written as doxorubicin, paclitaxel poliglumex, capecitabine, cyclophosphamide, methotrexateHow we know
- Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate CancerTerminatedPhase 2OHSU Knight Cancer InstituteNCT00459810Written as paclitaxel poliglumexHow we know
- A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung CancerTerminatedPhase 2Washington University School of MedicineNCT00352690Written as Paclitaxel poliglumexHow we know
- Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast CancerCompletedPhase 2Alliance for Clinical Trials in OncologyNCT00265733Written as paclitaxel poliglumexHow we know
- Efficacy and Safety Study of Xyotax to Treat Prostate CancerCompletedPhase 2The Methodist Hospital Research InstituteNCT00446836Written as Paclitaxel polyglumex (Xyotax)How we know
- Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube CancerCompletedPhase 1Gynecologic Oncology GroupNCT00060359Written as Paclitaxel PoliglumexHow we know
- A Pilot Study of PPX in Women With Metastatic Colorectal CancerCompletedPhase 1University of Southern CaliforniaNCT00598247Written as Paclitaxel PoliglumexHow we know
- Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC)CompletedPhase 2Dartmouth-Hitchcock Medical CenterNCT00487669Written as paclitaxel poliglumex, pemetrexedHow we know
- CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal CancerCompletedPhase 1/2Memorial Sloan Kettering Cancer CenterNCT00017017Written as paclitaxel poliglumexHow we know
- CT-2103 in Combination With Gemcitabine in Metastatic Breast CancerCompletedPhase 1M.D. Anderson Cancer CenterNCT00270907Written as CT-2103How we know
- Phase II CT-2103/Carboplatin in Ovarian CancerCompletedPhase 2CTI BioPharmaNCT00069901Written as CT-2103 (poly(L)glutamate-paclitaxel)How we know
- Study of Xyotax (CT-2103) in Patients With Metastatic Breast CancerCompletedPhase 2Dana-Farber Cancer InstituteNCT00148707Written as CT-2103 (Xyotax)How we know
Given beside what is tested · 1 — paclitaxel poliglumex is usual care or a partner of the new treatment
Codes
What other systems call paclitaxel poliglumex · ClinicalTrials.gg INT004890
- MeSH (NLM) C509139paclitaxel poliglumexConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) TQ64FZ98ZNPACLITAXEL POLIGLUMEXConfirmed FDA, NLM, Wikidata
- RxNorm 2473230One source FDA
- Wikidata Q72499389paclitaxel poliglumexConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1795Paclitaxel PoliglumexOne source FDA
- DrugBank DB13809One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C509139 | paclitaxel poliglumex | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | TQ64FZ98ZN | PACLITAXEL POLIGLUMEX | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2473230 | — | One source FDA |
| Wikidata | Q72499389 | paclitaxel poliglumex | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1795 | Paclitaxel Poliglumex | One source FDA |
| DrugBank | DB13809 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.